Trials / Terminated
TerminatedNCT01522586
Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031
A Dose Block-randomized, Double-blind, Placebo-controlled, Single/Multiple Dosing, Dose-escalation Clinical Phase 1 Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of orally administrated DWP09031 in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP09031 | DWP09031 50mg/100mg/400mg/200mg/800mg/1200mg/1600mg/2000mg single dosing |
| DRUG | Placebo | placebo comparator 50mg/100mg/400mg/200mg/800mg/1200mg/1600mg/2000mg single dosing |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-05-01
- Completion
- 2013-12-01
- First posted
- 2012-01-31
- Last updated
- 2014-02-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01522586. Inclusion in this directory is not an endorsement.